Abeona Therapeutics (ABEO) Tops Q2 EPS by 7c

Abeona Therapeutics (NASDAQ: ABEO) reported Q2 EPS of ($0.26), $0.07 better than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.

You May Also Be Interested In

• List of suppliers, parts, photos of iPhone 18 Pro are part of Tata Electronics data breach - Reuters
• Maersk sees FY underlying EBITDA of $8-$10B vs $4.5B-$7B prior
• Fortune Brands Innovations (FBIN) call put ratio 10.7 calls to 1 put with a focus on 3700 contracts of July 55 calls, share price up 10.7%